Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Net Margin: 2019-2024

Historic Net Margin for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to -9.80%.

  • Eton Pharmaceuticals' Net Margin fell 1465.00% to -8.58% in Q3 2025 from the same period last year, while for Sep 2025 it was -12.19%, marking a year-over-year decrease of 260.00%. This contributed to the annual value of -9.80% for FY2024, which is 684.00% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its Net Margin stood at -9.80% for FY2024, which was down 231.29% from -2.96% recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Net Margin high stood at -2.96% for FY2023, and its period low was -71,717.95% during FY2020.
  • Its 3-year average for Net Margin is -18.40%, with a median of -9.80% in 2024.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Net Margin crashed by 6,980,763bps in 2020, and later soared by 7,170,899bps in 2021.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Net Margin stood at -71,717.95% in 2020, then soared by 7,170,899bps to -8.95% in 2021, then plummeted by 3,350bps to -42.45% in 2022, then skyrocketed by 3,949bps to -2.96% in 2023, then plummeted by 684bps to -9.80% in 2024.